Supporting innovation: clear approval pathways and evidence standards for AI-driven digital health technologies
Jeanette Kusel explains how we are working in partnership to improve patient access to the best digital health innovations.
Jeanette Kusel explains how we are working in partnership to improve patient access to the best digital health innovations.
New functionality for online collaboration on consultations, enables groups or organisations to submit a joined-up response.
Two exciting developments which will accelerate NICE’s efforts to deliver innovation to the health and care system faster.
The Innovative Licensing and Access Pathway (ILAP) will smooth the process by which innovative new medicines are developed, speeding their progression from clinical trial through to the NHS, bringing significant benefits to patients.
NICE has been part of a research project investigating how quality of life measures used to evaluate healthcare treatments such as drugs can be extended into areas of social care and public health.
The European Health Data and Evidence Network (EHDEN) project could support faster patient access to innovative medicines in areas of unmet need.
Page 8 of 9